Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 1.15 USD -1.54% Market Closed
Market Cap: 3.8m USD

Intrinsic Value

RDHL doesn't have a meaningful market cap.

The intrinsic value of one RDHL stock under the Base Case scenario is 9.64 USD. Compared to the current market price of 1.15 USD, Redhill Biopharma Ltd is Undervalued by 88%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RDHL Intrinsic Value
9.64 USD
Undervaluation 88%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Redhill Biopharma Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about RDHL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RDHL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Redhill Biopharma Ltd.

Explain Valuation
Compare RDHL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RDHL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Redhill Biopharma Ltd

Current Assets 12.6m
Cash & Short-Term Investments 2.9m
Receivables 5.4m
Other Current Assets 4.3m
Non-Current Assets 5.8m
PP&E 289k
Intangibles 5.5m
Current Liabilities 22.3m
Accounts Payable 835k
Accrued Liabilities 10.7m
Other Current Liabilities 10.8m
Non-Current Liabilities 500k
Other Non-Current Liabilities 500k
Efficiency

Free Cash Flow Analysis
Redhill Biopharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Redhill Biopharma Ltd

Revenue
12.1m USD
Cost of Revenue
-4.8m USD
Gross Profit
7.3m USD
Operating Expenses
-26.3m USD
Operating Income
-19m USD
Other Expenses
6.6m USD
Net Income
-12.4m USD
Fundamental Scores

RDHL Profitability Score
Profitability Due Diligence

Redhill Biopharma Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Exceptional Gross Margin
41/100
Profitability
Score

Redhill Biopharma Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

RDHL Solvency Score
Solvency Due Diligence

Redhill Biopharma Ltd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
31/100
Solvency
Score

Redhill Biopharma Ltd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RDHL Price Targets Summary
Redhill Biopharma Ltd

There are no price targets for RDHL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Redhill Biopharma Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for RDHL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one RDHL stock?

The intrinsic value of one RDHL stock under the Base Case scenario is 9.64 USD.

Is RDHL stock undervalued or overvalued?

Compared to the current market price of 1.15 USD, Redhill Biopharma Ltd is Undervalued by 88%.

Back to Top